MoneyWorks4Me

Aurobindo Pharma informs about investors meet

09 Jan 2023 Evaluate

Aurobindo Pharma has informed that the officials of the Company will be participating in meetings with various investors. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is submitted pursuant to Regulation 30(6) of the Listing Regulations. The schedule of the meeting is attached.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..